The SAPA-China 2024 Pharmaceutical Industry Conference will be held at the Suzhou Shishan International Convention Center on October 18–19, 2024. The conference will focus on topics such as large and small molecules, cell gene therapy, AI pharmaceuticals, nucleic acids, GLP-1 and metabolism, clinical trials, radionuclide-coupled drugs, overseas cooperation, investments and financing, and other urgent topics. More than 300 scholars from top global research institutions and leaders of large multinational pharmaceutical and biotechnology companies will gather to deliver breakthrough reports, with more than 7,000 professionals expected to attend it.

Dr. Sean Lin, founder and CEO of ChemLex, will attend the AI Forum and deliver the keynote speech on “Automation and Intelligence in Chemical Synthesis.” He will also participate in roundtable discussions. Meanwhile, we will organize a booth (number A74) at the event site. We welcome everyone to an on-site exchange.

ChemLex provides disruptive CRO services with its proprietary AI-driven automated system for chemical synthesis. It has developed a high-throughput automated system to replace manual operations and AI models to design synthetic routes. This AI-driven automated system provides CRO services with significantly higher efficiency and ESG values.

Website:www.chemlex.com
E-mail: inquiry@chemlex.com